2014, Number s3
<< Back Next >>
Gac Med Mex 2014; 150 (s3)
Evolution of endovascular treatment compared with medical and surgical treatment in patients with aortic syndrome type B
Eid-Lidt G, Hernández JG, González-Pacheco H, Meléndez- Ramírez G, Molina MJ, Cervantes SJL, Ramírez MS
Language: Spanish
References: 34
Page: 298-305
PDF size: 270.84 Kb.
ABSTRACT
Introduction: Surgical treatment is accepted as conventional treatment of patients with acute aortic syndrome associated
to ischemic complications. Promising results of thoracic endovascular aortic repair (TEVAR) has expanded its indication
to a variety of thoracic aorta pathologies. Objectives: The objective of this study was to evaluate the safety and efficacy
of TEVAR during the in-hospital period and at mid-term follow-up, and compare with medical and surgical treatment in
patients who presented with acute aortic syndrome (AAS) type B.
Material and methods: Of 113 patients that fulfilled
the inclusion criteria, 58 underwent endovascular treatment (Group 1), 34 had medical treatment (Group 2), and 21 had
surgical treatment (Group 3).
Results: Global and cardiovascular in-hospital mortality was superior in Group 3 (p = 0.0001).
Mean follow-up was 30.4 ± 12.2 months. The survival rate free from cardiovascular death was 92.5, 60.5, and 42.9, in
Group 1, 2, and 3, respectively, at 36 months.
Conclusions: Our results suggest that endovascular treatment is feasible,
safe, and associated with a reduction of in-hospital and mid-term major adverse cardiovascular events, and superior
survival rate compared with surgical and medical treatment.
REFERENCES
Vilacosta I, San Roman JA. Acute aortic syndrome. Heart. 2001;85: 365-8.
Nienaber CA, Powell JT. Management of acute aortic syndromes. Eur Heart J. 2012;33:26-35.
Evangelista A, Padilla F, López-Ayerbe J, et al. Spanish acute aortic syndrome study (RESA). Better diagnosis is not reflected in reduced mortality. Rev Esp Cardiol. 2009;62:255-62.
Tsai TT, Fattori R, Trimarchi S, et al. Long-term survival in patients presenting with type B acute aortic dissection. Insights from the international registry of acute aortic dissection. Circulation. 2006;114:2226-31.
Clough RE, Mani K, Lyons OT, et al. Endovascular treatment of acute aortic syndrome. J Vasc Surg. 2011;54:1580-7.
Grabenwoger M, Alfonso F, Bachet J, et al. Thoracic endovascular aortic repair (TEVAR) for the treatment of aortic diseases: a position statement from the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Intervention (EAPCI): Eur Heart J. 2012;33:1558-63.
Nienaber C, Fattori R, Lund G, et al. Nonsurgical reconstruction of thoracic aortic dissection by stent-grafts placement. N Egl J Med. 1999;340:1539-45.
Dake MD, Kato N, Mitchell RS, et al. Endovascular stent-graft placement for the treatment of acute aortic dissection. N Engl J Med. 1999;340:1546-52.
Svensson LG, Kouchoukos NT, Miller C. Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts. Ann Thorac Surg. 2008;85:S1-41.
Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease: executive summary. J Am Coll Cardiol. 2010;55:1509-1544.
Trimarchi S, Eagle KA, Nienaber CA, et al. Importance of refractory pain and hypertension in acute type B aortic dissection. Insights from the international registry of acute aortic dissection (IRAD). Circulation. 2010;122:1283-9.
Fattori R, Tsai TT, Myrmel T, et al. Complicated acute type B dissection: Is surgery still the best option?: a report from the International Registry of Acute Aortic Dissection. JACC Cardiovasc Interv. 2008;1(4):395-402.
Kato N, Hirano T, Ishida M, et al. Acute and contained rupture of the descending thoracic aorta: treatment with endovascular stent graft. J Vasc Surg. 2003;37:100-5.
Doss M, Balzer J, Martens S, et al. Surgical versus endovascular treatment of acute thoracic aortic rupture: a single-center experience. Ann Thorac Surg. 2003;76:1465-70.
Scheinert D, Krankenberg H, Schmidt A, et al. Endoluminal stent-graft placement for acute rupture of the descending thoracic aorta. Eur Heart J. 2004;25:694-700.
Jonker FH, Verhagen H, Lin P, et al. Outcomes of endovascular repair of ruptured descending thoracic aortic aneurysms. Circulation. 2010;121:2718-23.
Patel HJ, Williams DM, Upchurch GR, Dasika NL, Deeb GM. A comparative analysis of open and endovascular repair for the ruptured descending thoracic aorta. J Vasc Surg. 2009;50:1265-70.
Jonker FH, Verhagen HJ, Lin PH, et al. Open surgery versus endovascular repair of ruptured thoracic aortic aneurysms. J Vasc Surg. 2011;53:1210-6.
Jonker FH, Trimarchi S, Verhagen H, Moll FL, Sumpio BE, Muhs BE. Meta-analysis of open versus endovascular repair for ruptured descending thoracic aortic aneurysm. J Vasc Surg. 2010;51:1026-32.
O`Donnell S, Geotchues A, Beavers F, et al. Endovascular management of acute aortic dissections. J Vasc Surg. 2011;54:1283-9.
Tsai TT, Trimarchi S, Nienaber CA. Acute aortic dissection: perspective from the International Registry of Aortic Dissection (IRAD). Eur J Vasc Endovasc Surg. 2009;37:149-59.
Manning BJ, Dias N, Manno M, et al. Endovascular treatment of acute complicated type B dissection: morphological changes at mid-term follow-up. J Endovasc Ther. 2009;16:466-74.
Patel HJ, Williams DM, Meekov M, Dasika NL, Upchurch GR, Deeb GM. Long-term results of percutaneous management of malperfusion in acute type B aortic dissection: implications for thoracic endovascular repair. J Thorac Cardiovasc Surg. 2009;138:300-8.
Sachs T, Pomposelli F, Hagberg R, et al. Open and endovascular repair of type B aortic dissection in the Nationwide Inpatient Sample. J Vasc Surg. 2010;52:860-6.
Xenos ES, Abedi NN, Davenport DL, et al. Meta-analysis of endovascular vs open repair for traumatic descending thoracic aortic rupture. J Vasc Surg. 2008;48:1343-51.
Eggebrecht H, Plicht B, Kahlert P, Erbel R. Intramural hematoma and penetrating ulcers: indications to endovascular treatment. Eur J Vasc Endovasc Surg. 2009;38:659-65.
Harris KM, Braverman AC, Eagle KA, et al. Acute aortic hematoma: An analysis from the international registry of acute aortic dissection. Circulation. 2012;126:S91-6.
Evangelista A, Salas A, Ribera A, et al. Long-term outcome of aortic dissection with patent false lumen. Predictive role of entry tear and location. Circulation. 2012;125:3133-41.
Ince H, Rehders T, Petzsch M, Kische S, Nienaber C. Stent-graft in patients with Marfan syndrome. J Endovasc Ther. 2005;12:82-8.
Gaxotte V, Thony F, Rousseau H, et al. Midterm results of aortic diameter outcomes after thoracic sstent-graft implantation for aortic dissection: A multicenter study. J Endovasc Ther. 2006;13:127-38.
Geisbusch P, Kotelis D, von Tengg-Kobligk H, Hyhlik-Durr A, Allenger JR, Bokler D. Thoracic aortic endografting in patients with connective tissue diseases. J Endovasc Ther. 2008;15:144-9.
Marcheix B, Rosseau H, Bongard V, et al. Stent grafting of dissected descending aorta in patients with Marfan´s syndrome. Mid-term results. JACC Cardiovasc Interv. 2008;1(6):673-80.
Cooper DG, Walsh SR, Sadat U, Hayes PD, Boyle JR. Treating the thoracic aorta in Marfan syndrome: Surgery or TEVAR. J Endovasc Ther. 2009;16:60-70.
Eid-Lidt G, Ramirez S, Damas DF, Cervantes J. Aortic remodeling after thoracic aortic stent-graft in patients with Marfan syndrome. Am J Cardiol. 2008;102:222i-23i [abstract].